PDAP1

28 kDa heat- and acid-stable phosphoprotein · Q13442 · PDAP1 on Sugi Atlas →

0 patent compounds predicted against PDAP1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PDAP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer PHASE2UNKNOWN
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB PHASE2COMPLETED
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Novel Peptide Vaccination for Patients With Advanced Bladder Cancer PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies PHASE1WITHDRAWN
FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma PHASE1WITHDRAWN
Investigation of Secreted Phosphoproteins and PiP3 (Phosphoinositolphospat 3) in Sputum nanCOMPLETED
Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly nanUNKNOWN
Perfusion-Induced Hyperthermia for Metastatic Carcinoma nanCOMPLETED
Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm nanCOMPLETED
Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases. nanNOT_YET_RECRUITING
Evaluation of CEMIP in Pancreatic Cancer nanUNKNOWN
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer nanCOMPLETED
Pathogenetic Basis of Aortopathy and Aortic Valve Disease nanACTIVE_NOT_RECRUITING
Reducing Heart Failure Risk in Late-Life With Physical Activity nanNOT_YET_RECRUITING
Exercise on Expression of Heat Shock Protein 70 in Arterial Risk nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Identification of Biomarkers for Early Detection of Pancreatic Cancer nanCOMPLETED
Phosphoproteomic Profile of Children With Down Syndrome nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Sialic Acid in Hepatocellular Carcinoma nanNOT_YET_RECRUITING
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection nanUNKNOWN
Biomarkers in Idiopathic Juvenile Arthritis nanUNKNOWN
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PDAP1 binder may also engage these)

ProteinNameSimilarity
Q3UHX2 1.000 Q3UHX2 →
Q62785 1.000 Q62785 →
Q8GWI5 0.997 Q8GWI5 →
C5DP87 0.993 C5DP87 →
A3N0X3 0.993 A3N0X3 →
Q65W23 0.993 Q65W23 →
Q6FSQ0 0.993 Q6FSQ0 →
Q8FBG9 0.992 Q8FBG9 →
B0BPQ7 0.992 B0BPQ7 →
Q05D44 0.992 Q05D44 →
Q6K8D9 0.992 Q6K8D9 →
Q568K9 0.992 Q568K9 →
C5A034 0.992 C5A034 →
Q9CSN1 0.992 Q9CSN1 →
Q2VPH1 0.992 Q2VPH1 →
Q755Z1 0.992 Q755Z1 →
Q6YDN7 0.992 Q6YDN7 →
Q8X8G9 0.992 Q8X8G9 →
P0CR57 0.991 P0CR57 →
Q3YVA7 0.991 Q3YVA7 →
Q299F9 0.991 Q299F9 →
P0A8H6 0.991 P0A8H6 →
Q6CLA4 0.991 Q6CLA4 →
B2GUV7 0.991 B2GUV7 →
Q18691 0.991 Q18691 →
P40470 0.991 P40470 →
P53317 0.991 P53317 →
Q6DB75 0.991 Q6DB75 →
B1JR11 0.991 B1JR11 →
Q28BK4 0.991 Q28BK4 →